Standout Papers
Citation Impact
Citing Papers
Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
2008 Standout
Autonomic Nerve Development Contributes to Prostate Cancer Progression
2013 StandoutScience
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
Dual Angiotensin Receptor and Neprilysin Inhibition as an Alternative to Angiotensin-Converting Enzyme Inhibition in Patients with Chronic Systolic Heart Failure: Rationale for and Design of the Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure Trial (PARADIGM-HF)
2013
Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy
2010 StandoutNobel
Oral Torsemide in Patients With Chronic Congestive Heart Failure: Effects on Body Weight, Edema, and Electrolyte Excretion
1994
Angiotensin II receptor antagonists in heart failure: Rationale and design of the evaluation of losartan in the elderly (ELITE) trial
1995
Diastolic dysfunction as a cause of heart failure
1993
The prevention of heart failure in minority communities and discrepancies in health care delivery systems
2004
Rationale and design of the valsartan heart failure trial: A large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure
1999
Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure
1992
Guidelines for the diagnosis and treatment of chronic heart failure
2001
The prognosis of heart failure in the general population. The Rotterdam Study
2001
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 Standout
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations
2003
Treatment guidelines in heart failure
1998
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
1996 Standout
Left ventricular hypertrophy: An initial response to myocardial injury
1992
Nonpharmacologic Therapy Improves Functional and Emotional Status in Congestive Heart Failure
1994
Optimizing therapy for complex or refractory heart failure: A management algorithm
1998
The Use of Contrast-Enhanced Magnetic Resonance Imaging to Identify Reversible Myocardial Dysfunction
2000 Standout
Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure
1995
Serial exercise testing and prognosis in selected patients considered for cardiac transplantation
1998
Wound repair and regeneration
2008 StandoutNature
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>
2003 Standout
Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction
2001
Association between a Deletion Polymorphism of the Angiotensin-Converting-Enzyme Gene and Left Ventricular Hypertrophy
1994
Effects of Vesnarinone on Morbidity and Mortality in Patients with Heart Failure
1993
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A–deficient mice
2001 StandoutNobel
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway
1999 StandoutNobel
Cost-effectiveness Analysis in Clinical Practice
1999
Effect of quinapril on blood pressure and heart rate in congestive heart failure
1992
Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention1European Society of Cardiology, European Atherosclerosis Society, European Society of Hypertension, International Society of Behavioural Medicine, European Society of General Practice/Family Medicine, European Heart Network.1,2Published simultaneously in the European Heart Journal 1998;19:1434–1503 and the Journal of Hypertension (Summary only) 1998;16(10).2
1998
Lisinopril in the Treatment of Congestive Heart Failure in Elderly Patients: Comparison versus Captopril
1997
Amiodarone in Patients with Congestive Heart Failure and Asymptomatic Ventricular Arrhythmia
1995
Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C
2012 Standout
Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: The Hy-C trial
1992
Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary β2-adrenergic receptor gene delivery
1999 StandoutNobel
The epidemiology of heart failure: The Framingham Study
1993 Standout
Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study
2002
Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure
2004
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
2001 Standout
Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure
1993
Successes and failures of current treatment of heart failure
1998
Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system
2005 StandoutNobel
Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia
1996 Standout
Cardiac Resynchronization in Chronic Heart Failure
2002 Standout
Potentiation of beta-adrenergic signaling by adenoviral-mediated gene transfer in adult rabbit ventricular myocytes.
1997 StandoutNobel
The Management of Chronic Heart Failure
1996
Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: A randomized, double-blind, placebo-controlled study
1994
Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure
1996
Effect of the Insertion/Deletion Polymorphism of the Angiotensin-Converting Enzyme Gene on Response to Angiotensin-Converting Enzyme Inhibitors in Patients with Heart Failure
1998
Effect of enalapril on congestive heart failure treated with diuretics in elderly patients with prior myocardial infarction and normal left ventricular ejection fraction
1993
Management of heart failure. IV. Anticoagulation for patients with heart failure due to left ventricular systolic dysfunction
1994
Task Force on Sudden Cardiac Death of the European Society of Cardiology
2001
Evolving trends in the epidemiologic factors of heart failure: Rationale for preventive strategies and comprehensive disease management
1997
Comprehensive multidisciplinary programs for the management of patients with congestive heart failure
1999
Circadian variation in the effects of aldosterone blockade on heart rate variability and QT dispersion in congestive heart failure
2001
Women and mexican Americans receive fewer cardiovascular drugs following myocardial infarction than men and non-hispanic whites: The Corpus Christi Heart Project, 1988–1990
1996
Heart failure
2005
Obesity and the Risk of Heart Failure
2002 Standout
Adverse effects of enalapril in the Studies of Left Ventricular Dysfunction (SOLVD)
1996
Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study
2003
Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
1997 Standout
Lesser Response to Angiotensin-Converting–Enzyme Inhibitor Therapy in Black as Compared with White Patients with Left Ventricular Dysfunction
2001
Clinical consequences of angiotensin-converting enzyme inhibitor withdrawl in chronic heart failure: A double-blind, placebo-controlled study of quinapril
1993
Cholinergic innervation and function in the prostate gland
2002
Prevalence and Incidence of Arrhythmias and Sudden Death in Heart Failure
2002
Angiotensin‐Converting Enzyme Inhibitor Use in Older Patients with Heart Failure and Renal Dysfunction
1999
Toleration of High Doses of Angiotensin-Converting Enzyme Inhibitors in Patients With Chronic Heart Failure
2001
Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy
1996
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)
2005 Standout
Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
2014 Standout
Quality of Care by Race and Gender for Congestive Heart Failure and Pneumonia
1999
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
1999 Standout
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
2006 Standout
The Hallmarks of Aging
2013 Standout
Prevalence and mortality rate of congestive heart failure in the United States
1992
Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction
2003 Standout
Heart failure in the 1990s: Evolutions of a major public health problem in cardiovascular medicine
1993
Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors
2000
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
2005 Standout
Summary of Recommendations
2002
Double-Blind Placebo-Controlled Study of Ibopamine and Diagoxin in Patients With Mild to Moderate Heart Failure: Results of the Dutch of the Ibopamine Multicenter Trial (DIMT)
1993
Calcium Channel Blockers in Heart Failure
1998
Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling
2000 Standout
Linkage of β1-adrenergic stimulation to apoptotic heart cell death through protein kinase A–independent activation of Ca2+/calmodulin kinase II
2003 StandoutNobel
Drugs, Heart Failure and Quality of Life
1999
Racial differences in response to therapy for heart failure: Analysis of the vasodilator-heart failure trials
1999
Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure
2002 Standout
Diabetes mellitus and congestive heart failure
1999
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
2010 Standout
Baseline demographics of the Valsartan Heart Failure Trial
2000
Effect of Amiodarone on Clinical Status and Left Ventricular Function in Patients With Congestive Heart Failure
1996
Angiotensin Receptors and Their Therapeutic Implications
1996
Expression of a β-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice
1998 StandoutNobel
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Chronic Heart Failure in the United States
1998
Effects of Long-term Enalapril Therapy on Cardiac Structure and Function in Patients With Left Ventricular Dysfunction
1995
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Blockade of the Renin-Angiotensin System in Cardiac Pressure-Overload Hypertrophy in Rats
1995
Myocyte Recovery After Mechanical Circulatory Support in Humans With End-Stage Heart Failure
1998
Digitalis Therapy for Patients in Clinical Heart Failure
2004
PROGNOSIS IN CONGESTIVE HEART FAILURE
1994
Prophylactic Use of Implanted Cardiac Defibrillators in Patients at High Risk for Ventricular Arrhythmias after Coronary-Artery Bypass Graft Surgery
1997
Augmented Short- and Long-Term Hemodynamic and Hormonal Effects of an Angiotensin Receptor Blocker Added to Angiotensin Converting Enzyme Inhibitor Therapy in Patients With Heart Failure
1999
α 1 -Adrenergic Receptors and Their Inhibitors in Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia
2004
The Progression From Hypertension to Congestive Heart Failure
1996 Standout
Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Organic Nitrates in Patients With Chronic Heart Failure Treated With Angiotensin-Converting Enzyme Inhibition
1999
Evaluating Quality of Care for Patients With Heart Failure
2000
Overexpression of angiotensin AT 1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block
1997 StandoutNobel
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness
2005
Effect of the Calcium Antagonist Felodipine as Supplementary Vasodilator Therapy in Patients With Chronic Heart Failure Treated With Enalapril
1997
Task force 3: Recipient guidelines/prioritization
1993
Failure to Improve Left Ventricular Function After Coronary Revascularization for Ischemic Cardiomyopathy Is Not Associated With Worse Outcome
1999
Angiotensin-Converting Enzyme Inhibitors
1998
Linkage of β1-adrenergic stimulation to apoptotic heart cell death through protein kinase A–independent activation of Ca2+/calmodulin kinase II
2003 StandoutNobel
Congestive Heart Failure in the Community
1998
Exercise Capacity and Mortality among Men Referred for Exercise Testing
2002 Standout
?Escape? of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: Implications for therapy
1995
Resource Use and Survival of Patients Hospitalized with Congestive Heart Failure: Differences in Care by Specialty of the Attending Physician
2000
Clinical, Hemodynamic, and Cardiopulmonary Exercise Test Determinants of Survival in Patients Referred for Evaluation of Heart Failure
1998
Genetic Dissection of Complex Traits
1994 StandoutScience
Acute Coronary Findings at Autopsy in Heart Failure Patients With Sudden Death
2000
Cardiac βARK1 inhibition prolongs survival and augments β blocker therapy in a mouse model of severe heart failure
2001 StandoutNobel
Angiotensin-Converting–Enzyme Inhibition in Stable Coronary Artery Disease
2004
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
Left Ventricular Thrombus and the Incidence of Thromboembolism in Patients with Congestive Heart Failure: Can Clinical Factors Identify Patients at Increased Risk?
1995
Heart Rate Variability
1996 Standout
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
1999 StandoutScience
Combination of isosorbide dinitrate and hydralazine in blacks with heart failure
2005
Influence of β -Blockers on Mortality in Chronic Heart Failure
2000
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
Prevention of coronary heart disease in clinical practice Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention
1998
Reduced growth, abnormal kidney structure, and type 2 (AT 2 ) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT 1A and AT 1B receptors for angiotensin II
1998 StandoutNobel
Management of Heart Failure
1994
Effects of Continuous Positive Airway Pressure on Obstructive Sleep Apnea and Left Ventricular Afterload in Patients With Heart Failure
1998
Pharmacological Options in the Treatment of Benign Prostatic Hyperplasia
1997
Works of Clair Haakenson being referenced
The Efficacy of Terazosin, Finasteride, or Both in Benign Prostatic Hyperplasia
1996
A Comparison of Enalapril with Hydralazine–Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart Failure
1991 Standout
THE IMPACT OF MEDICAL THERAPY ON BOTHER DUE TO SYMPTOMS, QUALITY OF LIFE AND GLOBAL OUTCOME, AND FACTORS PREDICTING RESPONSE
1998
THE IMPACT OF MEDICAL THERAPY ON BOTHER DUE TO SYMPTOMS, QUALITY OF LIFE AND GLOBAL OUTCOME, AND FACTORS PREDICTING RESPONSE
1998